StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies profit margin

Profit margin (net margin) is net income as a percentage of revenue.

AXIM Biotechnologies's profit margin for the twelve months ending Jun 30, 2024 was -4452.1%. For fiscal 2023 it was -20395.0%, against -70343.1% the year before. The highest annual figure on record is -27.9% in fiscal 2011.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-20395.0%+49948.1
FY2022Dec 31, 2022-70343.1%−43825.9
FY2021Dec 31, 2021-26517.2%−25710.7
FY2019Dec 31, 2019-806.5%+2646.6
FY2018Dec 31, 2018-3453.0%+5308.7
FY2017Dec 31, 2017-8761.7%+3584.3
FY2016Dec 31, 2016-12346.0%+8193.2
FY2015Dec 31, 2015-20539.2%−20127.4
FY2013Dec 31, 2013-411.8%−377.4
FY2012Dec 31, 2012-34.4%−6.5
FY2011Dec 31, 2011-27.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-12986.0%+24513.2
Q1 FY2024Mar 31, 2024-551.7%+36796.2
Q4 FY2023Dec 31, 2023-14793.0%−2902.4
Q3 FY2023Sep 30, 20233428.3%+158264.5
Q2 FY2023Jun 30, 2023-37499.2%+129878.0
Q1 FY2023Mar 31, 2023-37348.0%+3155.0
Q4 FY2022Dec 31, 2022-11890.6%+13836.6
Q3 FY2022Sep 30, 2022-154836.1%−152188.2
Q4 FY2021Dec 31, 2021-167377.2%−167197.6
Q3 FY2021Sep 30, 2021-40503.0%−26771.8
Q2 FY2021Jun 30, 2021-25727.2%−25140.9
Q1 FY2021Mar 31, 2021-2648.0%+18780.3
Q4 FY2019Dec 31, 2019-179.6%+20355.8
Q1 FY2019Mar 31, 2019-13731.2%+5664.5
Q4 FY2018Dec 31, 2018-586.3%+8714.5
Q3 FY2018Sep 30, 2018-21428.3%−4604.1
Q2 FY2018Jun 30, 2018-20535.4%−5427.4
Q1 FY2018Mar 31, 2018-19395.6%−16580.6
Q4 FY2017Dec 31, 2017-9300.7%+390.5
Q3 FY2017Sep 30, 2017-16824.2%+1755.4
Q2 FY2017Jun 30, 2017-15108.0%+1692.7
Q1 FY2017Mar 31, 2017-2815.0%+3997.5
Q4 FY2016Dec 31, 2016-9691.2%+31311.9
Q3 FY2016Sep 30, 2016-18579.6%−10695.8
Q2 FY2016Jun 30, 2016-16800.7%−3915.3
Q1 FY2016Mar 31, 2016-6812.6%–
Q4 FY2015Dec 31, 2015-41003.1%–
Q3 FY2015Sep 30, 2015-7883.8%–
Q2 FY2015Jun 30, 2015-12885.5%–

More AXIM Biotechnologies figures

See a number that looks wrong?